Researchers at the University of New South Wales (UNSW) in Sydney, Australia, have used CRISPR gene editing technology t...
Cellmid Limited announced that it has entered into an agreement with Labo International S.r.l to undertake the exclusive...
Indian biotech major Biocon said that the biosimilar insulin glargine co-developed with US drug major partner Mylan rece...
Australia's Mayne Pharma Group recently announced the launch of doxycycline monohydrate immediate release (IR...
Propanc Biopharma Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatm...
The Australian Council on Healthcare Standards (ACHS), Australia's leading independent authority on healthcare, has reco...
Australia’s biotech giant Immutep has announced that it has entered into a clinical trial collaboration and supply...
Phase I clinical trials to assess its safety, human tolerance, and pharmacokinetic properties. XW10172 is the first comp...
A team of scientists from the Walter and Eliza Hall Institute of Medical Research in Australia have discovered a unique ...
Globally, the radiopharmaceutical medicine market is expected to reach USD 13.8 billion by 2024, according to a new repo...
In a bid to further broaden its immune-oncology portfolio, Merck has recently acquired Australian firm Viralytics ...
Australian firm Atomo Diagnostics has collaborated with US-based biotechnology company RPS Diagnostics for the developme...
The commercialisation company of The University of Queensland (UQ), Australia announced collaboration with Zealand Pharm...
Mundipharma recently announced the acquisition of specialist pharmaceutical company, Tolmar Australia , including exclus...
US firm PCI Pharma Services (PCI) has announced the acquisition of Australia-based Pharmaceutical Packaging Professional...
MedTech pioneer Proteomics International has entered into a strategic alliance with CPR Pharma Services (CPR), targeting...
A group of researchers from Queensland University of Technology, Australia has identified a drug that could potenti...
Global pharma giant Allergen has struck a deal to acquire Australia's Elastagen , a clinical stage company developing me...
Researchers at Florey Institute of Neuroscience and Mental Health, and University of Melbourne, Australia and Japanese N...
Australia’s Starpharma today announced that it has received regulatory and ethics approvals to commence its phase ...
Cynata Therapeutics has signed a Memorandum of Understanding (MoU) with Celularity Inc., a US-based biotech company focu...
FuturaGene is a wholly owned subsidiary of Suzano Pulp and Paper, and Australia’s Commonwealth Scientific and Indu...
A team of scientists at University of Queensland’s Institute for Molecular Bioscience, Australia has modified an o...
Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and pr...
A seasoned biotech executive of over 20 years, Dr Deborah Rathjen joined Bionomics in June 2000 from Peptech Limited, wh...